healthcare.digital October 17, 2025
Major developments in European HealthTech this week have been dominated by major funding rounds in biotech, significant regulatory alignment and continued investment in digital health.
Here are the key highlights:
1. Record-Breaking Funding Rounds
German Biotech Tubulis secured a €308 million Series C financing round. This is reported as the largest Series C ever raised by a European biotech and the largest private financing globally for an antibody-drug conjugate (ADC) developer. The funds will advance their cancer therapies, including a lead candidate in a Phase I/IIa study.
Finnish HealthTech Oura (the smart ring maker) raised substantial fresh funding, valuing the company at around $11 billion, and plans to accelerate AI and product innovation globally.
British investor Spex Capital announced the...
Today's Sponsors
Today's Sponsor